Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Method comparison for N-glycan profiling: Towards the standardization of glycoanalytical technologies for cell line analysis.

Kotsias M, Blanas A, van Vliet SJ, Pirro M, Spencer DIR, Kozak RP.

PLoS One. 2019 Oct 7;14(10):e0223270. doi: 10.1371/journal.pone.0223270. eCollection 2019.

2.

Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.

Moosavian SA, Bianconi V, Pirro M, Sahebkar A.

Semin Cancer Biol. 2019 Oct 1. pii: S1044-579X(19)30098-7. doi: 10.1016/j.semcancer.2019.09.025. [Epub ahead of print] Review.

PMID:
31585213
3.

Regulation of cardiac stem cells by microRNAs: State-of-the-art.

Gorabi AM, Bianconi V, Pirro M, Banach M, Sahebkar A.

Biomed Pharmacother. 2019 Sep 30;120:109447. doi: 10.1016/j.biopha.2019.109447. [Epub ahead of print] Review.

4.

The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu.

Mahdavi Gorabi A, Banach M, Reiner Ž, Pirro M, Hajighasemi S, Johnston TP, Sahebkar A.

J Clin Med. 2019 Sep 8;8(9). pii: E1413. doi: 10.3390/jcm8091413. Review.

5.

PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography.

Panahi Y, Ghahrodi MS, Jamshir M, Safarpour MA, Bianconi V, Pirro M, Farahani MM, Sahebkar A.

Clin Biochem. 2019 Sep 4. pii: S0009-9120(19)30255-3. doi: 10.1016/j.clinbiochem.2019.09.001. [Epub ahead of print]

PMID:
31493378
6.

CD47: role in the immune system and application to cancer therapy.

Hayat SMG, Bianconi V, Pirro M, Jaafari MR, Hatamipour M, Sahebkar A.

Cell Oncol (Dordr). 2019 Aug 14. doi: 10.1007/s13402-019-00469-5. [Epub ahead of print] Review.

PMID:
31485984
7.

Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry.

Gheibi Hayat SM, Bianconi V, Pirro M, Sahebkar A.

Int J Pharm. 2019 Oct 5;569:118628. doi: 10.1016/j.ijpharm.2019.118628. Epub 2019 Aug 14. Review.

PMID:
31421198
8.

Efferocytosis and Atherosclerosis: Regulation of Phagocyte Function by MicroRNAs.

Tajbakhsh A, Bianconi V, Pirro M, Gheibi Hayat SM, Johnston TP, Sahebkar A.

Trends Endocrinol Metab. 2019 Sep;30(9):672-683. doi: 10.1016/j.tem.2019.07.006. Epub 2019 Aug 2. Review.

PMID:
31383556
9.

Radio Frequency Angular Momentum Biased Quasi-LTI Nonreciprocal Acoustic Filters.

Cassella C, Michetti G, Pirro M, Yu Y, Kord A, Sounas D, Alu A, Rinaldi M.

IEEE Trans Ultrason Ferroelectr Freq Control. 2019 Jul 25. doi: 10.1109/TUFFC.2019.2931121. [Epub ahead of print]

PMID:
31352343
10.

Emerging roles for high-density lipoproteins in neurodegenerative disorders.

Bahrami A, Barreto GE, Lombardi G, Pirro M, Sahebkar A.

Biofactors. 2019 Sep;45(5):725-739. doi: 10.1002/biof.1541. Epub 2019 Jul 13. Review.

PMID:
31301192
11.

The role of high-density lipoproteins in antitumor drug delivery.

Sarhadi S, Ganjali S, Pirro M, Sahebkar A.

IUBMB Life. 2019 Oct;71(10):1442-1452. doi: 10.1002/iub.2105. Epub 2019 Jul 10. Review.

PMID:
31290612
12.

Toll-like receptors as novel therapeutic targets for herpes simplex virus infection.

Jahanban-Esfahlan R, Seidi K, Majidinia M, Karimian A, Yousefi B, Nabavi SM, Astani A, Berindan-Neagoe I, Gulei D, Fallarino F, Gargaro M, Manni G, Pirro M, Xu S, Sadeghi M, Nabavi SF, Shirooie S.

Rev Med Virol. 2019 Jul;29(4):e2048. doi: 10.1002/rmv.2048. Epub 2019 Jul 2. Review.

PMID:
31265195
13.

Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy.

Saliba-Gustafsson P, Pedrelli M, Gertow K, Werngren O, Janas V, Pourteymour S, Baldassarre D, Tremoli E, Veglia F, Rauramaa R, Smit AJ, Giral P, Kurl S, Pirro M, de Faire U, Humphries SE, Hamsten A; IMPROVE Study Group, Gonçalves I, Orho-Melander M, Franco-Cereceda A, Borén J, Eriksson P, Magné J, Parini P, Ehrenborg E.

J Intern Med. 2019 Jun 28. doi: 10.1111/joim.12951. [Epub ahead of print]

PMID:
31251843
14.

PCSK9 and inflammation: a review of experimental and clinical evidence.

Momtazi-Borojeni AA, Sabouri-Rad S, Gotto AM, Pirro M, Banach M, Awan Z, Barreto GE, Sahebkar A.

Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):237-245. doi: 10.1093/ehjcvp/pvz022.

PMID:
31236571
15.

Modulation of regulatory T cells by natural products in cancer.

Bahrami A, Fereidouni M, Pirro M, Bianconi V, Sahebkar A.

Cancer Lett. 2019 Sep 10;459:72-85. doi: 10.1016/j.canlet.2019.06.001. Epub 2019 Jun 6.

PMID:
31176742
16.

Commentary to "The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease".

Mannarino MR, Bianconi V, Pirro M.

High Blood Press Cardiovasc Prev. 2019 Jun;26(3):259-261. doi: 10.1007/s40292-019-00317-5. Epub 2019 May 7. No abstract available.

PMID:
31065891
17.

Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study.

Francisci D, Pirro M, Schiaroli E, Mannarino MR, Cipriani S, Bianconi V, Alunno A, Bagaglia F, Bistoni O, Falcinelli E, Bury L, Gerli R, Mannarino E, De Caterina R, Baldelli F.

Open Forum Infect Dis. 2019 Mar 7;6(4):ofz112. doi: 10.1093/ofid/ofz112. eCollection 2019 Apr.

18.

A review of gene- and cell-based therapies for familial hypercholesterolemia.

Hajighasemi S, Mahdavi Gorabi A, Bianconi V, Pirro M, Banach M, Ahmadi Tafti H, Reiner Ž, Sahebkar A.

Pharmacol Res. 2019 May;143:119-132. doi: 10.1016/j.phrs.2019.03.016. Epub 2019 Mar 22. Review.

PMID:
30910740
19.

Mast cell tryptase - Marker and maker of cardiovascular diseases.

Mohajeri M, Kovanen PT, Bianconi V, Pirro M, Cicero AFG, Sahebkar A.

Pharmacol Ther. 2019 Jul;199:91-110. doi: 10.1016/j.pharmthera.2019.03.008. Epub 2019 Mar 12. Review.

PMID:
30877022
20.

Effects of a 3-month weight-bearing and resistance exercise training on circulating osteogenic cells and bone formation markers in postmenopausal women with low bone mass.

Pasqualini L, Ministrini S, Lombardini R, Bagaglia F, Paltriccia R, Pippi R, Collebrusco L, Reginato E, Sbroma Tomaro E, Marini E, D'Abbondanza M, Scarponi AM, De Feo P, Pirro M.

Osteoporos Int. 2019 Apr;30(4):797-806. doi: 10.1007/s00198-019-04908-9. Epub 2019 Feb 26.

PMID:
30809725
21.

Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials.

Sahebkar A, Simental-Mendía LE, Katsiki N, Reiner Ž, Banach M, Pirro M, Atkin SL.

BMJ Open. 2019 Feb 22;8(11):e021508. doi: 10.1136/bmjopen-2018-021508.

22.

Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies.

Pirro M, Simental-Mendía LE, Bianconi V, Watts GF, Banach M, Sahebkar A.

J Clin Med. 2019 Jan 18;8(1). pii: E118. doi: 10.3390/jcm8010118. Review.

23.

Dietary natural products as emerging lipoprotein(a)-lowering agents.

Momtazi-Borojeni AA, Katsiki N, Pirro M, Banach M, Rasadi KA, Sahebkar A.

J Cell Physiol. 2019 Aug;234(8):12581-12594. doi: 10.1002/jcp.28134. Epub 2019 Jan 13. Review.

PMID:
30637725
24.

Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells.

Pirro M, Schoof E, van Vliet SJ, Rombouts Y, Stella A, de Ru A, Mohammed Y, Wuhrer M, van Veelen PA, Hensbergen PJ.

J Proteome Res. 2019 Mar 1;18(3):1125-1132. doi: 10.1021/acs.jproteome.8b00796. Epub 2019 Jan 9.

25.

Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials.

Sahebkar A, Simental-Mendía LE, Pirro M, Banach M, Watts GF, Sirotri C, Al-Rasadi K, Atkin SL.

Sci Rep. 2018 Dec 14;8(1):17887. doi: 10.1038/s41598-018-36204-7.

26.

Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence.

Ricciuti B, Leonardi GC, Puccetti P, Fallarino F, Bianconi V, Sahebkar A, Baglivo S, Chiari R, Pirro M.

Pharmacol Ther. 2019 Apr;196:105-116. doi: 10.1016/j.pharmthera.2018.12.004. Epub 2018 Dec 4. Review.

PMID:
30521884
27.

High-Density Lipoprotein Components and Functionality in Cancer: State-of-the-Art.

Ganjali S, Ricciuti B, Pirro M, Butler AE, Atkin SL, Banach M, Sahebkar A.

Trends Endocrinol Metab. 2019 Jan;30(1):12-24. doi: 10.1016/j.tem.2018.10.004. Epub 2018 Nov 22. Review.

PMID:
30473465
28.

Editorial commentary: Atherosclerosis and immunity: A perspective.

Pirro M, Mannarino MR.

Trends Cardiovasc Med. 2019 Aug;29(6):372-373. doi: 10.1016/j.tcm.2018.11.005. Epub 2018 Nov 15. No abstract available.

PMID:
30471984
29.

NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial.

Pirro M, Francisci D, Bianconi V, Schiaroli E, Mannarino MR, Barsotti F, Spinozzi A, Bagaglia F, Sahebkar A, Baldelli F.

Atherosclerosis. 2019 Jan;280:51-57. doi: 10.1016/j.atherosclerosis.2018.11.026. Epub 2018 Nov 14.

PMID:
30471555
30.

A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes.

Yaribeygi H, Atkin SL, Pirro M, Sahebkar A.

J Cell Physiol. 2019 Jun;234(6):8286-8294. doi: 10.1002/jcp.27699. Epub 2018 Nov 11. Review.

PMID:
30417367
31.

PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results?

Mannarino MR, Sahebkar A, Bianconi V, Serban MC, Banach M, Pirro M.

J Clin Lipidol. 2018 Sep - Oct;12(5):1123-1132. doi: 10.1016/j.jacl.2018.05.012. Epub 2018 May 31. Review.

PMID:
30318062
32.

In silico evidence of direct interaction between statins and β-amyloid.

Shakour N, Bianconi V, Pirro M, Barreto GE, Hadizadeh F, Sahebkar A.

J Cell Biochem. 2019 Mar;120(3):4710-4715. doi: 10.1002/jcb.27761. Epub 2018 Sep 27.

PMID:
30260016
33.

Efferocytosis: molecular mechanisms and pathophysiological perspectives.

Gheibi Hayat SM, Bianconi V, Pirro M, Sahebkar A.

Immunol Cell Biol. 2019 Feb;97(2):124-133. doi: 10.1111/imcb.12206. Epub 2018 Oct 16. Review.

PMID:
30230022
34.

Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials.

Sahebkar A, Simental-Mendía LE, Mikhailidis DP, Pirro M, Banach M, Sirtori CR, Reiner Ž.

Ann Med. 2018 Nov;50(7):565-575. doi: 10.1080/07853890.2018.1511919. Epub 2018 Sep 29.

PMID:
30102092
35.

The Role of Efferocytosis in Autoimmune Diseases.

Abdolmaleki F, Farahani N, Gheibi Hayat SM, Pirro M, Bianconi V, Barreto GE, Sahebkar A.

Front Immunol. 2018 Jul 20;9:1645. doi: 10.3389/fimmu.2018.01645. eCollection 2018. Review.

36.

Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials.

Sahebkar A, Simental-Mendía LE, Pirro M, Montecucco F, Carbone F, Banach M, Barreto GE, Butler AE.

Ann Med. 2018 Sep;50(6):485-493. doi: 10.1080/07853890.2018.1495338. Epub 2018 Sep 7.

PMID:
29957074
37.

S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cells.

Romani R, Manni G, Donati C, Pirisinu I, Bernacchioni C, Gargaro M, Pirro M, Calvitti M, Bagaglia F, Sahebkar A, Clerici G, Matino D, Pomili G, Di Renzo GC, Talesa VN, Puccetti P, Fallarino F.

Eur J Pharmacol. 2018 Aug 15;833:173-182. doi: 10.1016/j.ejphar.2018.06.005. Epub 2018 Jun 7.

38.

High density lipoprotein cholesterol and cancer: Marker or causative?

Pirro M, Ricciuti B, Rader DJ, Catapano AL, Sahebkar A, Banach M.

Prog Lipid Res. 2018 Jul;71:54-69. doi: 10.1016/j.plipres.2018.06.001. Epub 2018 Jun 4. Review.

PMID:
29879431
39.

Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.

Bianconi V, Mannarino MR, Sahebkar A, Cosentino T, Pirro M.

Curr Cardiol Rep. 2018 May 25;20(7):53. doi: 10.1007/s11886-018-0994-7. Review.

PMID:
29802549
40.

Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy.

Pirro M, Bianconi V, Schiaroli E, Francisci D, Mannarino MR, Bagaglia F, Sahebkar A, Merriman T, Baldelli F.

Atherosclerosis. 2018 May;272:101-107. doi: 10.1016/j.atherosclerosis.2018.03.031. Epub 2018 Mar 17.

PMID:
29597116
41.

Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials.

Sahebkar A, Simental-Mendía LE, Mikhailidis DP, Pirro M, Banach M, Sirtori CR, Ruscica M, Reiner Ž.

J Clin Lipidol. 2018 May - Jun;12(3):801-809. doi: 10.1016/j.jacl.2018.01.008. Epub 2018 Feb 1.

42.

IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases.

Teymouri M, Pirro M, Fallarino F, Gargaro M, Sahebkar A.

Int J Cancer. 2018 Nov 1;143(9):2105-2115. doi: 10.1002/ijc.31382. Epub 2018 Mar 31. Review.

PMID:
29574719
43.

Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study.

Paciullo F, Proietti M, Bianconi V, Nobili A, Pirro M, Mannucci PM, Lip GYH, Lupattelli G; REPOSI Investigators.

Drugs Aging. 2018 Apr;35(4):365-373. doi: 10.1007/s40266-018-0532-8.

PMID:
29564755
44.

[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018].

Volpe M, Tocci G, Accettura D, Battistoni A, Bellone S, Bellotti P, Bertolotti M, Borghi C, Casasco M, Consoli A, Coppini R, Corsini A, Costanzo G, Desideri G, Ferri C, Galanti G, Giada F, Icardi G, Lombardi N, Modena MG, Modesti PA, Monti G, Mugelli A, Orsi A, Parati G, Pedretti RF, Perseghin G, Pirro M, Ricotti R, Rizzoni D, Rotella C, Rubattu S, Salvetti G, Sarto P, Tassinari F, Trimarco B, de Kreutzenberg SV, Volpe R.

G Ital Cardiol (Rome). 2018 Feb;19(2 Suppl 1):1S-95S. doi: 10.1714/2874.28988. Italian.

PMID:
29531376
45.

Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?

De Giglio A, Porreca R, Brambilla M, Metro G, Prosperi E, Bellezza G, Pirro M, Chiari R, Ricciuti B.

Thromb Res. 2018 Mar;163:51-53. doi: 10.1016/j.thromres.2017.12.004. Epub 2017 Dec 9. No abstract available.

PMID:
29353684
46.

Improvement of endothelial function by pitavastatin: a meta-analysis.

Katsiki N, Reiner Ž, Tedeschi Reiner E, Al-Rasadi K, Pirro M, Mikhailidis DP, Sahebkar A.

Expert Opin Pharmacother. 2018 Feb;19(3):279-286. doi: 10.1080/14656566.2018.1428560. Epub 2018 Jan 18. Review.

PMID:
29334477
47.

Oxidative burden in familial hypercholesterolemia.

Mollazadeh H, Carbone F, Montecucco F, Pirro M, Sahebkar A.

J Cell Physiol. 2018 Aug;233(8):5716-5725. doi: 10.1002/jcp.26466. Epub 2018 Mar 7. Review.

PMID:
29323716
48.

Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications.

Ricciuti B, Foglietta J, Chiari R, Sahebkar A, Banach M, Bianconi V, Pirro M.

Med Oncol. 2017 Dec 4;35(1):4. doi: 10.1007/s12032-017-1064-5. Review.

PMID:
29209837
49.

Curcumin as an Adjunct Therapy and microRNA Modulator in Breast Cancer.

Norouzi S, Majeed M, Pirro M, Generali D, Sahebkar A.

Curr Pharm Des. 2018;24(2):171-177. doi: 10.2174/1381612824666171129203506. Review.

PMID:
29189128
50.

Simulation Models of Therapy Intensification in Lipid-Lowering Medicine: Fact or Fantasy?

Calabrò P, Gragnano F, Pirro M.

JAMA Cardiol. 2018 Jan 1;3(1):88-89. doi: 10.1001/jamacardio.2017.4344. No abstract available.

PMID:
29188280

Supplemental Content

Support Center